This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Roche Molecular Systems, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Colin Lam: Innovator in Genetic Engineering
Introduction
Colin Lam is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of bacteriophage-based technologies. His work focuses on creating innovative solutions for bacteria-related diseases.
Latest Patents
Colin Lam holds a patent for "Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems." This invention relates to compositions and methods for producing genetically engineered bacteriophages and non-replicating transduction particles (NRTPs) that feature non-native tail fibers. These modifications allow for altered host specificity and reactivity. The patent also outlines methods for utilizing these bacteriophages and NRTPs in the development of novel diagnostics, therapeutics, and research reagents aimed at combating bacteria-related diseases. He has 1 patent to his name.
Career Highlights
Colin Lam is currently employed at Roche Molecular Systems, Inc., where he continues to advance his research in genetic engineering. His work at Roche has positioned him as a key player in the development of innovative solutions for healthcare.
Collaborations
Colin collaborates with talented individuals in his field, including coworkers Kyle C. Cady and Jeffrey Alexander. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Colin Lam's innovative work in genetic engineering and his contributions to bacteriophage technology highlight his importance in the field. His patent and ongoing research at Roche Molecular Systems, Inc. demonstrate his commitment to developing solutions for bacteria-related diseases.